>>Signaling Pathways>> Apoptosis>> PD-1/PD-L1 interaction>>Vudalimab

Vudalimab

Catalog No.GC70137

Vudalimab는 효과적인 PD-1 및 CTLA-4 이중 억제제로, 완전 인간화된 이중 특이 단일 클론 항체입니다. Vudalimab는 면역 점검점 수용 체 PD-1 및 CTLA-4를 대상으로 하여 종양 선택적 T 세포 활성을 촉진합니다.

Products are for research use only. Not for human use. We do not sell to patients.

Vudalimab Chemical Structure

Cas No.: 2329669-72-7

Size 가격 재고 수량
5mg
US$850.50
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Chemical Properties Product Documents

리뷰

Review for Vudalimab

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Vudalimab

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.